BRABANT PHARMA
Brabant Pharma is a single purpose company developing an oral treatment (“Brabafen”) suitable for use in children with Dravet Syndrome (otherwise known as severe myoclonic epilepsy of infancy). Dravet Syndrome is a rare form of childhood epilepsy associated with catastrophic seizures resulting in mental and cognitive impairment. Approximately 10%-15% of children die as a direct result. Patients are unresponsive to normal anticonvulsants. Based on the incidence of Dravet Syndrome, the n... ew treatment will qualify as an Orphan Product in Europe and the United States (US), receiving data exclusivity for 10 and 7 years respectively. Brabant has licensed exclusive access to new clinical data using up to 20 years of case studies showing exceptional efficacy for the treatment in children with Dravet Syndrome which are frequently unresponsive to standard anticonvulsants.
BRABANT PHARMA
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2013-01-01
Address:
Hanoi, NA - Vietnam, Vietnam
Country:
Vietnam
Website Url:
http://www.brabantpharma.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
GlaucoPharm
GlaucoPharm is developing TG-46, a novel topical treatment for glaucoma.
VersaPeutics
VersaPeutics is a biotech startup devoted to finding treatment for disorders of the nervous system.
ViAqua Therapeutics
ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.
Investors List
Aquarius Equity Partners
Aquarius Equity Partners investment in Venture Round - Brabant pharma
Official Site Inspections
http://www.brabantpharma.com
Unable to get host informations!!!
More informations about "Brabant pharma"
Brabant pharma - Crunchbase Company Profile & Funding
Brabant Pharma is a single purpose company developing an oral treatment (“Brabafen”) suitable for use in children with Dravet Syndrome (otherwise known as severe myoclonic epilepsy of …See details»
Brabant Pharma Company Profile | Management and Employees …
Find contact information for Brabant Pharma. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Brabant Pharma's email format.See details»
Brabant Pharma - VentureRadar
"Brabant has licensed exclusive access to new clinical data utilising up to 20 years of case studies showing exceptional efficacy for the treatment in children with Dravet Syndrome which are …See details»
Brabant Pharma Limited Company Profile, Financial and
Brabant Pharma Limited develops Brabafen, an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was incorporated in 2012 …See details»
Brabant Pharma - Products, Competitors, Financials, Employees ...
Brabant Pharma is a single purpose company developing an oral treatment ("Brabafen") suitable for use in children with Dravet Syndrome (otherwise known as severe myoclonic epilepsy of …See details»
Brabant Pharma - Ownership and Business Overview | Mergr
Oct 27, 2014 Where is Brabant Pharma headquartered? Brabant Pharma is headquartered in Manchester, United Kingdom. What sector is Brabant Pharma in? Brabant Pharma is a life …See details»
Brabant Pharma - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Brabant Pharma. Use the PitchBook Platform to explore the full profile.See details»
Brabant Pharma:Company Profile & Technical …
Brabant pharma is a company that provides Dravet syndrome, Health care, Pharmacy and Therapeutics and more. Brabant pharma is headquartered in Vietnam NA - Vietnam. Brabant …See details»
Brabant Pharma - Company Profile - Tracxn
Brabant Pharma was developing therapeutics for rare CNS diseases such as Dravet Syndrome. Its lead drug Brabafen is low-dose fenfluramine and is being developed for children suffering …See details»
Brabant Pharma Limited Brabant Pharma Limited - 6sense.com
Find useful insights on Brabant Pharma Limited’s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Brabant Pharma …See details»
Brabant Pharma - CB Insights
Explore {Brabant Pharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Zogenix Acquires U.K.-Based Brabant Pharma | Fierce Biotech
SAN DIEGO, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain …See details»
Brabant Pharma - VentureRadar
Brabant has licensed exclusive access to new clinical data utilising up to 20 years of case studies showing exceptional efficacy for the treatment in children with Dravet Syndrome which are …See details»
Zogenix Inc. has acquired Brabant Pharma
<p>Brabant's assets include worldwide development and commercialisation rights to Brabafen, low-dose fenfluramine, for the treatment of Dravet Syndrome.</p>See details»
Zogenix acquires U.K.-based Brabant Pharma | Drug Discovery News
Oct 28, 2014 SAN DIEGO— Zogenix, Inc., a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) …See details»
Company Details :: In Vivo
Want to become a subscriber?Subscribers get more company details, updates, company financials and company products.See details»
Brabant Pharma Reports Grant Of Orphan Drug Designation In U …
Jan 9, 2014 About Brabant Pharma: Brabant Pharma is a privately held specialty pharmaceutical company developing a new low-dose formulation of fenfluramine specifically formulated to …See details»
Brabant pharma Culture | Comparably
Learn about Brabant pharma's culture, see what work's like, read reviews, and find job opportunities.See details»
Brabant Pharma Reports Grant of Orphan Drug Designation in U.S.
Jan 9, 2014 Brabant Pharma announced today that both the U.S. Food and Drug Administration and the European Commission have granted orphan drug designation to Brabafen® for use in …See details»
Pharmaceutical Company Organizational Structure Guide
2 days ago A pharmaceutical company organization chart is a vital tool in helping all employees understand how the business works. A pharmaceutical company organizational structure …See details»